Skip to main content

Advertisement

Log in

Type 2 Diabetes Mellitus in Patients with Mild Obesity: Preliminary Results of Surgical Treatment

  • Clinical Report
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

In the last years, type 2 diabetes mellitus (T2DM) and obesity have become a serious public health problem, behaving as epidemic diseases. There is great interest in exploring different options for the treatment of T2DM in nonmorbidly obese patients. The purpose of this study is to report parameters of glycemic control in patients with T2DM and mild obesity who underwent laparoscopic Roux-en-Y gastric bypass (RYGBP). This prospective clinical trial includes patients with T2DM with a body mass index (BMI) between 30 and 35 kg/m2 who underwent laparoscopic RYGBP from July 2008 through October 2010. Thirty-one patients were included in the study, 15 men and 16 women, with an average age of 48.7 ± 8.6 years. The average time since onset of T2DM was 5.8 years. The average postoperative follow-up was 30.4 months. The average preoperative blood glucose and glycosylated hemoglobin were 152 ± 70 mg/dl and 7.7 ± 2.1 %, respectively. All of them were using oral hypoglycemic agents, and four patients were insulin dependent. Only one patient had a postoperative complication (hemoperitoneum). At 36 months follow-up, the average BMI decreased to 24.7 kg/m2, all patients (31) showed improvement in their glycemic control, and 29 of them (93.6 %) met the criteria for remission of T2DM in the last control. Laparoscopic RYGBP is a safe and effective procedure that improves glycemic control in patients with T2DM and mild obesity at midterm follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Zimmet P. The burden of type 2 diabetes: are we doing enough? Diabetes Metab. 2003;29:9–18.

    Article  Google Scholar 

  2. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.

    Article  PubMed  Google Scholar 

  3. Instituto Nacional de Estadisticas (National Statistics Institute, Chile). Encuesta Nacional de Salud (National Health Survey). MINSAL 2003

  4. Donnelly R, Emslie-Smith A, Gardner I, et al. Complications of Diabetes. BMJ. 2000;320:1062–6.

    Article  PubMed  CAS  Google Scholar 

  5. Geiss L, Herman W, Smith P. Mortality in non insulin-dependent diabetes.”Diabetes in America” 2nd edition. National diabetes data group. National Health Institutes. National Institute of Diabetes and Digestive and Kidney Diseases NIH Publication. 1995;95:1468.

  6. Haffner S, Lehto S, Rönnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with or without prior myocardial infarction. N Eng J Med. 1998;339:229–34.

    Article  CAS  Google Scholar 

  7. UK Prospective Diabetes Study Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPD 34). Lancet. 1998;352:854–65.

    Article  Google Scholar 

  8. Heine R, Diamant M, Mbanya J-C, et al. Management of hyperglycemia in type 2 diabetes: the end of recurrent failure? BMJ. 2006;333:1200–4.

    Article  PubMed  CAS  Google Scholar 

  9. Dailey G, Kim M, Lian J. Patient compliance and persistence with anti-hyperglycemic therapy: evaluation of a population of type 2 diabetic patients. J Int Med Res. 2002;30:71–9.

    PubMed  CAS  Google Scholar 

  10. Kahn S, Haffner S, Heise M, et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med. 2006;355:2427–43.

    Article  PubMed  CAS  Google Scholar 

  11. Dormandy J, Charbonnel B, Eckland D, et al. On behalf of the PROactive Investigators. Secondary prevention on macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet. 2005;366:1279–89.

    Article  PubMed  CAS  Google Scholar 

  12. Lago R, Singh P, Nesto R. Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. Lancet. 2007;370:1129–36.

    Article  PubMed  CAS  Google Scholar 

  13. Parks M, Rosenbraugh C. Weighing risks and benefits of liraglutide—the FDA’s review of a new anidiabetic therapy. N Eng J Med. 2010;362:774–7.

    Article  CAS  Google Scholar 

  14. Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg. 2002;236:554–9.

    Article  PubMed  Google Scholar 

  15. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.

    Article  PubMed  CAS  Google Scholar 

  16. Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232:515–29.

    Article  PubMed  CAS  Google Scholar 

  17. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339–50.

    Article  PubMed  CAS  Google Scholar 

  18. Ramos AC. Galvao Neto MP, de Souza YM, et al. Laparoscopic duodenal–jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI < 30 kg/m2 (LBMI). Obes Surg. 2009;19:307–12.

    Article  PubMed  Google Scholar 

  19. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32:2133–5.

    Article  PubMed  Google Scholar 

  20. Rubino F, Schauer P, Kaplan L, et al. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med. 2010;61:393–411.

    Article  PubMed  CAS  Google Scholar 

  21. Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Eng J Med. 2007;357:741–52.

    Article  Google Scholar 

  22. Sjöström L, Gummesson A, Sjöström CD, et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective controlled intervention trial. Lancet Oncol. 2009;10:653–62.

    Article  PubMed  Google Scholar 

  23. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61.

    Article  PubMed  CAS  Google Scholar 

  24. Christou NV, Sampalis JS, Liberman N, et al. Surgery decreases long-term mortality, morbidity and health care use in morbidly obese patients. Ann Surg. 2004;240:416–24.

    Article  PubMed  Google Scholar 

  25. Csendes A, Burdiles P, Papapietro K, et al. Review of the results of medical and surgical treatment of morbid obesity. Rev Méd Chile. 2009;137:559–66.

    PubMed  Google Scholar 

  26. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56.

    Article  PubMed  Google Scholar 

  27. Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.

    Article  PubMed  Google Scholar 

  28. Csendes A, Papapietro K, Burgos AM, et al. Efecto del by pass gástrico a largo plazo (7 a 10 años) en pacientes con obesidad severa y mórbida sobre el peso corporal, diabetes, dyslipidemia y desarrollo de anemia. Rev Med Chil. 2011;139:1423–9.

    Google Scholar 

  29. Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. J Am Med Assoc. 2008;299:316–23.

    Article  CAS  Google Scholar 

  30. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577–85.

    Article  PubMed  CAS  Google Scholar 

  31. Schauer P, Kashyap S, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567–76.

    Article  PubMed  CAS  Google Scholar 

  32. American Diabetes Association. Standards of medical care in diabetes 2009. Diabetes Care. 2009;32:S13–61.

    Article  Google Scholar 

  33. Lee W, Wang W, Lee Y, et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI > 35 and <35 kg/m2. J Gastrointest Surg. 2008;12:945–52.

    Article  PubMed  Google Scholar 

  34. DePaula A, Macedo A, Rassi N, et al. Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc. 2008;22:706–16.

    Article  PubMed  CAS  Google Scholar 

  35. Ramos A, Galvão M, de Souza Y, et al. Laparoscopic duodenal–jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI < 30 kg/m2 (LBMI). Obes Surg. 2009;19:307–12.

    Article  PubMed  Google Scholar 

  36. Fried M, Ribaric J, Buchwald J, et al. Metabolic surgery for the treatment of type 2 diabetes in patients with BMI < 35 kg/m2: an integrative review of early studies. Obes Surg. 2010;20:776–90.

    Article  PubMed  CAS  Google Scholar 

  37. Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146:143–8.

    Article  PubMed  Google Scholar 

  38. Reis C, Alvarez-Leite J, Bressan J, et al. Role of bariatric–metabolic surgery in the treatment of obese type 2 diabetes with body mass index < 35 kg/m2: a literature review. Diabetes Technol Ther. 2012;14:365–72.

    Article  PubMed  CAS  Google Scholar 

  39. Lee WJ, Yul Hur K, Lakadawala M, et al. Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study. J Gastrointest Surg. 2012;16:45–62.

    Article  PubMed  Google Scholar 

  40. Buchwald H, Estok R, Fahrbach K, et al. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142:621–32.

    Article  PubMed  Google Scholar 

  41. Nguyen NT, Hinojosa M, Fayad C, et al. Use and outcomes of laparoscopic versus open gastric bypass at academic medical centers. J Am Coll Surg. 2007;205:248–55.

    Article  PubMed  Google Scholar 

  42. Lanzarini E, Csendes A, Lembach H, et al. Evolution of type 2 diabetes mellitus in non morbid gastrectomized patients with Roux en Y reconstruction: retrospective study. World J Surg. 2010;34:2098–102.

    Article  PubMed  Google Scholar 

Download references

Conflict of Interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Enrique Lanzarini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lanzarini, E., Csendes, A., Gutierrez, L. et al. Type 2 Diabetes Mellitus in Patients with Mild Obesity: Preliminary Results of Surgical Treatment. OBES SURG 23, 234–240 (2013). https://doi.org/10.1007/s11695-012-0780-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-012-0780-3

Keywords

Navigation